Origen de la red de primer grado David Bayles.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
42
| Public Company | Pharmaceuticals: Major | 42 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a David Bayles a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ASML HOLDING N.V. | Semiconductors | Director/Board Member | |
| CELGENE | Biotechnology | President Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ICU MEDICAL, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal General Counsel Director/Board Member Director/Board Member General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| THORATEC CORPORATION | Medical Specialties | Chairman Director/Board Member | |
| HSBC HOLDINGS PLC | Major Banks | Director/Board Member | |
DSM NV
 DSM NV Chemicals: SpecialtyProcess Industries DSM BV engages in the provision of ingredients, expertise, and solutions for plant-based products. It operates through the following segments: Animal Nutrition and Health (ANH); Health, Nutrition, and Care (HNC); Food and Beverage (F and B); and Other. The ANH segment includes developing sustainable animal farming through essential products, performance solutions, and precision services serving the poultry, swine, ruminants, and aquaculture markets. The HNC segment provides health, nutrition, and care solutions for markets such as early life nutrition, dietary supplements, pharma, medical, and personal care. The F and B segment focuses on supporting healthy diets through nutritious, delicious, and sustainable solutions for several market segments including bakery, beverages and brewing, dairy, savory, plant-based alternative proteins, and pet food. The Other segment is involved in corporate activities. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
Het Concertgebouw NV
 Het Concertgebouw NV Movies/EntertainmentConsumer Services Het Concertgebouw NV provides bands, orchestra and music entertainment services. It offers purchase tickets, tours, categories and charts. The company was founded on July 8, 1882 and is headquartered in Amsterdam, the Netherlands. | Movies/Entertainment | Director/Board Member | |
Mylan, Inc.
 Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Operating Officer Director/Board Member Chief Executive Officer President Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Public Communications Contact Director/Board Member Director/Board Member | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Mylan Pharmaceuticals, Inc.
 Mylan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mylan Pharmaceuticals, Inc. develops and manufactures generic prescription products. Its product includes tablets, Fosamax, Sectral, Xanax, capsules, liquids, and transdermal patches. The company was founded in 1961 and is headquartered in Morgantown, WV. | Pharmaceuticals: Major | President President President General Counsel | |
| MYLAN LABORATORIES LTD | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| ANACOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| MEDIVATION INC | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
Sandoz GmbH
 Sandoz GmbH Pharmaceuticals: MajorHealth Technology Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| The University of Chicago Booth School of Business | College/University | Founder Masters Business Admin | |
Viatris Healthcare (Pty) Ltd.
 Viatris Healthcare (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Viatris Healthcare (Pty) Ltd. manufactures pharmaceuticals. its products include prescription generic, branded generic, brand-name drugs and over-the-counter remedies. The company was founded in 1961 and is headquartered in Johannesburg, South Africa. | Pharmaceuticals: Major | Chairman President | |
| BIOATLA, INC. | Biotechnology | Director/Board Member Chief Operating Officer | |
| ZOETIS INC. | Pharmaceuticals: Major | President Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Healthcare Distribution Alliance
 Healthcare Distribution Alliance Miscellaneous Commercial ServicesCommercial Services Healthcare Distribution Alliance operates membership organizations. The firm distributes healthcare and pharmaceutical products. It delivers to pharmacies, hospitals, nursing homes, and health clinics. It provides members to share industry practices, represents member concerns before Congress and regulatory agencies, and publishes newsletters. The company is headquartered in Arlington, VA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Panjab University Chandigarh | College/University | Graduate Degree Graduate Degree | |
| Walden University LLC | College/University | Doctorate Degree | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member | |
| Ophthalmology Foundation | Director/Board Member | ||
| Drexel University College of Medicine | College/University | Graduate Degree | |
| Stony Brook University | College/University | Undergraduate Degree | |
| ABN AMRO BANK N.V. | Major Banks | Human Resources Officer | |
| Stichting Het Concertgebouw Fonds | Investment Trusts/Mutual Funds | Director/Board Member | |
| Economic Development Board Rotterdam | Corporate Officer/Principal | ||
| Erasmus University Rotterdam | College/University | Chief Executive Officer | |
| The Netherlands School for Public Administration | College/University | Director/Board Member | |
| University of Amsterdam | College/University | Graduate Degree | |
| Stichting VluchtelingenWerk Nederland | Director/Board Member | ||
| Duisenberg School of Finance | College/University | Director/Board Member | |
| Koninklijke Hollandsche Maatschappij der Wetenschappen | Director/Board Member | ||
| Rotterdam School of Management | College/University | Chief Executive Officer |
Estadísticas
Internacional
| Estados Unidos | 24 |
| Países Bajos | 14 |
| India | 4 |
| Reino Unido | 3 |
| Austria | 2 |
Sectorial
| Health Technology | 19 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Finance | 3 |
| Electronic Technology | 2 |
Operativa
| Director/Board Member | 191 |
| Corporate Officer/Principal | 75 |
| Independent Dir/Board Member | 66 |
| Chairman | 52 |
| President | 34 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| James Kilts | 48 |
| Pauline van der Meer Mohr | 34 |
| Ian Read | 29 |
| Douglas Giordano | 22 |
| Mark Parrish | 22 |
| Scott Smith | 21 |
| Wyllie Cornwell | 18 |
| Richard Mark | 17 |
| Elisha Finney | 17 |
| Neil Dimick | 16 |
| Melina Higgins | 14 |
| Rajiv Malik | 14 |
| Jeffrey Nau | 12 |
| Harry Korman | 12 |
| Robert Coury | 12 |
- Bolsa de valores
- Insiders
- David Bayles
- Conexiones Empresas
